Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04028492 · ClinicalTrials.gov registry record · Phase 3
Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
A Phase 3 study, sponsored by Vanda Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 992
- Enrollment target
NCT04028492: Completed Phase 3 study, sponsored by Vanda Pharmaceuticals.
NCT04028492 is a Phase 3 study that has completed, run by Vanda Pharmaceuticals. The registered enrollment target is 992 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (28% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04028492, a Phase 3 study, has completed, sponsored by Vanda Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 992 participants
- Enrollment target
Study Summary
To investigate the safety and efficacy of tradipitant versus placebo in relieving nausea and other symptoms of gastroparesis.
Primary Outcome
A daily symptom diary asking patients to rate their nausea on a Likert scale from 0-5 (0=none, 5= very severe).
Interventions
- DRUG Placebo
- DRUG Tradipitant
- DRUG Open Label Tradipitant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 992 participants |
| Start Date | 2019-08-20 |
| Est. Completion | 2025-02-21 |
| Phase | Phase 3 |
What the finished NCT04028492 record still lists
NCT04028492 is an interventional study that assigns participants to a tested intervention. The registered 992 participants enrollment target is mid-sized for trials with a published cap, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (28% higher).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04028492 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04028492 about?
NCT04028492 is a clinical study titled "Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis". To investigate the safety and efficacy of tradipitant versus placebo in relieving nausea and other symptoms of gastroparesis.
What is the current status of trial NCT04028492?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 992 participants. The study started on 2019-08-20. Estimated completion is 2025-02-21.
What interventions are being tested in trial NCT04028492?
The interventions under investigation include: Placebo (DRUG), Tradipitant (DRUG), Open Label Tradipitant (DRUG).
Who is sponsoring clinical trial NCT04028492?
This trial is sponsored by Vanda Pharmaceuticals, which has 68 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04028492's enrollment target sits among peer trials
992 314th of 2000 higher than 1,686 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05987241 · 992 participants · Phase 2
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
- NCT05437575 · 994 participants · Phase 3
Prehospital Analgesia INtervention Trial (PAIN)
- NCT06671704 · 994 participants · NA
GC-PRO Intervention
- NCT05441709 · 990 participants · NA
Furthering Equity Through Infant Feeding EDucation and Support
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI